This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Carol H. Wysham, ...
Glycogen storage disease type I (GSD I) is an autosomal recessive metabolic disorder caused by defects in the glucose-6-phosphatase complex. Deficient activity in the glucose-6-phosphatase-α catalytic ...
Adults with uncontrolled type 1 diabetes saw a benefit when using intermittently scanned continuous glucose monitoring (CGM), the randomized FLASH-UK Trial showed. Compared with traditional ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Older adults with type 1 diabetes initiating continuous ...
Remote monitoring is increasing as new reimbursement paths open up. But even the best programs are no guarantee of success.
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced compelling new clinical ...
Dexcom CGM use is proven to improve glycemic control 1,2 and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 3 BURNABY, British ...
South Wales Argus on MSN
Report: Continuous glucose monitoring helps manage blood sugar levels
A new report has found that continuous glucose monitoring has benefits beyond diabetes care ...
Apple Watch now supports glucose monitoring via CGMs like Dexcom G7, while Apple continues long-term work on non-invasive ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of continuous glucose monitoring was associated with ...
Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes researchers have found. That suggests doctors may be able to use data from the devices to help ...
Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback